C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2011
12/08/2011	WO2011151423A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors
12/08/2011	WO2011151320A1 Nitroimidazole derivatives
12/08/2011	WO2010109299A8 Substituted 1, 4-dioxa-8-azaspiro [4,5] decanes useful as fungicides and a process for the preparation thereof
12/08/2011	US20110301190 Polymorphic forms of a gabaa agonist
12/08/2011	US20110301160 Inhibitors of P38 and Methods of Using the Same
12/08/2011	US20110301155 Indazole compounds for activating glucokinase
12/08/2011	US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011	US20110301145 Pyridazinones, method of making, and method of use thereof
12/08/2011	CA2800668A1 New forms of rifaximin and uses thereof
12/08/2011	CA2799972A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
12/08/2011	CA2799653A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors
12/07/2011	EP2391621A2 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
12/07/2011	EP2144899B1 Epoxy compound and method for manufacturing the same
12/07/2011	CN102271671A 3，5-断-4-去甲-胆甾烷肟的新的衍生物、包含它们的药物组合物及其制备方法 3,5 breaking -4- norepinephrine - cholestane new oxime derivatives, pharmaceutical compositions containing them and preparation method
12/07/2011	CN102268015A 一种依维莫司的合成方法 Synthesis method everolimus
12/06/2011	USRE43003 Epothilone derivatives
12/06/2011	US8071614 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
12/06/2011	US8071593 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as Met kinase inhibitors for the treatment of tumours
12/06/2011	US8071592 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
12/06/2011	US8071591 7-cycloalkylaminoquinolones as GSK-3 inhibitors
12/06/2011	US8071590 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
12/06/2011	CA2570807C Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/01/2011	WO2011149250A2 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases
12/01/2011	WO2011148962A1 Novel heterocyclic compound or salt thereof
12/01/2011	WO2011147259A1 Novel benzoxazine oxazolidinone compounds, preparation methods and uses thereof
12/01/2011	WO2011092564A3 Process for the preparation of temsirolimus and its intermediates
12/01/2011	US20110294831 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
12/01/2011	US20110294827 Iap binding compounds
12/01/2011	US20110294801 Macrocyclics pyrimidines as aurora kinase inhibitors
12/01/2011	US20110294792 Purine derivatives as kinase inhibitors
12/01/2011	US20110294790 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
12/01/2011	US20110294784 Gamma secretase modulators
12/01/2011	US20110294783 Insecticidal Compositions Having Improved Effect
12/01/2011	US20110294780 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
12/01/2011	US20110294776 Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines IGF-1R Kinase Inhibitors for the Treatment of Cancer and Other Hyperproliferative Diseases
12/01/2011	US20110294756 Gamma secretase modulators
12/01/2011	US20110293654 SUBSTITUTED CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
12/01/2011	CA2800958A1 Macrocyclic compounds useful as inhibitors of histone deacetylases
11/2011
11/30/2011	EP2389379A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
11/30/2011	EP2389372A1 Compositions and methods for inhibition of the jak pathway
11/30/2011	CN102264369A 作为α2C肾上腺素受体激动剂的3，4-二氢-1，4-苯并噁嗪、3，4-二氢-1，4-苯并噻嗪和1，2，3，4-四氢-喹喔啉衍生物 As α2C adrenergic receptor agonists 3,4-dihydro-1,4-benzoxazine, 3,4-dihydro-1,4-benzothiazine and 1,2,3,4- Hydrogen - quinoxaline derivatives
11/30/2011	CN102260277A 新型苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 The new benzoxazine oxazolidinone compounds and their preparation and use
11/29/2011	US8067429 Forms of rifaximin and uses thereof
11/29/2011	US8067410 Phenolic and catecholic amines and prodrugs thereof
11/29/2011	CA2470447C Streptogramin derivatives, preparation thereof and compositions containing same
11/29/2011	CA2380359C Process for producing benzoxazine derivative and production intermediate thereof
11/24/2011	WO2011144578A1 Compounds
11/24/2011	US20110288291 Pyrazinooxazepine derivatives
11/24/2011	US20110288084 [4-( 1-amino-ethyl) - cyclohexyl ] - methyl - amines as antibacterials
11/24/2011	CA2799414A1 Spiro isoxazoline compounds as sstr5 antagonists
11/24/2011	CA2799337A1 Compounds
11/23/2011	EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
11/23/2011	EP2387572A2 Protein kinase c inhibitors and uses thereof
11/23/2011	EP1633758B1 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins
11/23/2011	CN102256983A Spiro-oxindole compounds and their use as therapeutic agents
11/23/2011	CN102250117A Dibenzoxazine containing oxazole ring and preparation method thereof
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN101356174B Indol-3-yl-carbonyl-spiro-piperidine derivatives
11/23/2011	CN101260115B Polymorphous forms of rifaximin, preparation and application thereof used in pharmaceutical preparation
11/22/2011	US8063063 Immunopotentiating compounds
11/22/2011	US8063044 Pyrazole derivatives
11/22/2011	US8063038 Heterocyclic condensed compounds useful as antidiuretic agents
11/22/2011	CA2484395C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
11/17/2011	WO2011142620A2 (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants
11/17/2011	WO2011142359A1 Spiro compound and drug for activating adiponectin receptor
11/17/2011	WO2011141848A1 Morpholine compounds as mineralocorticoid receptor antagonists
11/17/2011	WO2011113798A3 Inhibitors of semicarabazide - sensitive amine oxidase
11/17/2011	US20110282055 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
11/17/2011	US20110281903 Bicyclic heterocyclic spiro compounds
11/17/2011	US20110281874 2-aminopyridine analogs as glucokinase activators
11/17/2011	US20110281857 Pi3k/mtor kinase inhibitors
11/17/2011	US20110281854 Morpholine compounds
11/17/2011	US20110280867 Heterocyclic aspartyl protease inhibitors
11/17/2011	CA2798831A1 Morpholine compounds as mineralocorticoid receptor antagonists
11/16/2011	EP2386560A1 Crystalline clopidogrel naphthalenesulfonate hydrate, method for preparing same and pharmaceutical composition containing same
11/16/2011	EP2386558A1 CGRP antagonists
11/16/2011	CN102245615A Methods of treating hepatic encephalopathy
11/16/2011	CN102245605A Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
11/16/2011	CN102245585A Cyclic carbodiimide compounds
11/16/2011	CN102245181A Heterocyclic benzimidazoles as TRPM8 modulators
11/16/2011	CN102241720A L-nucleic acid derivative and processes for the synthesis thereof
11/16/2011	CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011	CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof
11/16/2011	CN101717404B Preparation process of levofloxacin carboxylic acid
11/16/2011	CN101367824B Preparation method for compound containing 1,2,3,11b-tetrahydric-[1,2] azine-[3,2-a] isoquinoline framework
11/16/2011	CN101084227B Rapamycin analogues and the uses thereof in the treatment of neurological disorders, proliferative diseases and inflammatory disease
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058425 Purine derivatives as kinase inhibitors
11/15/2011	US8058362 Manufacture of novel epoxy resins semi-thermosets and their high TG thermosets for electronic applications
11/15/2011	US8058288 Amido compounds and their use as pharmaceuticals
11/15/2011	US8058287 Chemokine receptor antagonists and methods of use therefor
11/15/2011	CA2685440C Process for producing benzoxazine derivative and production intermediate thereof
11/15/2011	CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
11/15/2011	CA2421791C Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
11/10/2011	WO2011140488A1 Pyridone and aza-pyridone compounds and methods of use
11/10/2011	WO2011140425A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
11/10/2011	WO2011139513A1 Compounds for the treatment of hepatitis c
11/10/2011	US20110275798 Method for Determination of Sirolimus Stability and Process for Preparing Its Stable Form

1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 220